Early HIV-1 envelope-specific cytotoxic T lymphocyte responses in vertically infected infants

Journal of Experimental Medicine

Volumn 185, Issue 7, 1997, Pages 1153-1161

  Pikora, Cheryl A ^a   Sullivan, John L ^a   Panicali, Dennis ^b   Luzuriaga, Katherine ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b Therion Biologics Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE REPORT; CELL SPECIFICITY; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; NEWBORN; PRIORITY JOURNAL; VERTICAL TRANSMISSION; VIRUS ENVELOPE; VIRUS TRANSMISSION;

CLONING, MOLECULAR; CROSS REACTIONS; DISEASE PROGRESSION; DISEASE TRANSMISSION, VERTICAL; GENE PRODUCTS, ENV; GENES, ENV; HEMATOPOIETIC STEM CELLS; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS;

EID: 0031000023     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.7.1153     Document Type: Article

References (25)

1. Report of a consensus workshop. 1992. Maternal factors involved in mother-to-child transmission of HIV-1. J. AIDS. 5:1019-1029.
2. Stoneburner, R.L., P. Sato, A. Burton, and T. Mertens. 1994. The global HIV pandemic. Acta Paediatr. (Suppl.). 400:1-4.
3. Connor, E.M., R.S. Sperling, R. Gelber, and the ACTG 076 Study Group. 1994. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. New Engl. J. Med. 331:1173-1180.
4. Luzuriaga, K., D. Holmes, A. Hereema, J. Wong, D.L. Panicali, and J.L. Sullivan. 1995. HIV-1-Specific cytotoxic T lymphocyte response in the first year of life. J. Immunol. 154:433-443.
5. McFaland, E.J., P.A. Harding, D. Luckey, B. Conway, R.K. Young, and D.R. Kuritzkes. 1994. High frequency of gag-and env-specific cytotoxic T lymphocyte precursors in children with vertically-acquired human immunodeficiency virus type 1 infection. J. Infect. Dis. 170:766-774.
6. Scarlatti, G., T. Leitner, E. Halapi, J. Wahlberg, P. Marchisio, M.A. Clerici-Schoeller, H. Wigzell, E.M. Fenyo, J. Albert, M. Uhlen et al. 1993. Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothers. Proc. Natl. Acad. Sci. USA. 90:1721-1725.
7. Wolinski, S.M., C.M. Wike, B.T.M. Korber, C. Hutto, W. Parks, L.L. Rosenblum, K.J. Kunstman, M.R. Furtado, and J.L. Munoz. 1992. Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science (Wash. DC). 255:1134-1137.
8. Selin, L.K., S.R. Nahill, and R.M. Welsh. 1994. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses J. Exp. Med. 179:1933-1943.
9. Bryson, Y.J., K. Luzuriaga, J.L. Sullivan, and D.W. Wara. 1992. Proposed definitions for in utero versus intrapartum transmission of HIV-1. N. Engl. J. Med. 327:1246-1247.
10. Boyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest. (Suppl). 21:77.
11. ACTG Virology Manual for HIV Laboratories. 1993. F.B. Hollinger, editor. National Institutes of Health, Bethesda, MD.
12. Delwart, E.L., E.G. Shpaer, G. Louwagie, F.E. McCutchen, M. Grez, H. Rubasamen-Waigmann, and J.I. Mullins. 1993. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science (Wash. DC). 262:1257-1261.
13. Mazzara, G.P., A. Destree, and A. Mahr. 1993. Generation and analysis of vaccinia virus recombinants. Methods Enzymol. 217:557-581.
14. Koup, R.A., C.A. Pikora, K. Luzuriaga, D.B. Brettler, E.S. Day, G.P. Mazzara, and J.L. Sullivan. 1991. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities. J. Exp. Med. 174:1593-1600.
15. Fazekas de St Groth, S. 1982. The evaluation of limiting dilution assays. J. Immunol. Methods. 49:R11.
16. Zhu, T., H. Mo, N. Wang, D.S. Nam, Y. Cao, R.A. Koup, and D.D. Ho. 1993. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science (Wash. DC). 261: 1179-1181.
17. Coffin, J.M. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis and therapy. Science (Wash. DC). 267:483-489.
18. Riviere, Y., F. Tanneau-Salvadori, A. Regnault, O. Lopez, P. Sansonetti, B. Guy, M.P. Kieny, J.J. Fournel, and L. Montagnier. 1989. Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env. J. Virol. 63:2270-2277.
19. Wong, J.T., and R.B. Colvin. 1991. Selective reduction and proliferation of the CD4+ and CD8+ T cell subsets with bispecific monoclonal antibodies: evidence for inter-T cell-mediated cytolosis. Clin. Immunol. Immunopathol. 58:236-250.
20. Centers for Disease Control. 1994. The 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR. 43:RR1-12.
21. Kusumi, K., B. Conway, S. Cunningham, A. Berson, C. Evans, A.K.N. Iversen, D. Colvin, M.V. Gallo, S. Coutre, E.G. Shpaer et al. 1992. Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro. J. Virol. 66:875-885.
22. Meyerhans, A., R. Cheynier, J. Albert, M. Seth, S. Kwok. J. Sninsky, L. Morfeldt-Manson, B. Asjo, and S. Wain-Hobson. 1989. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell. 58:901-910.
23. Borrow, P., H. Lewicki, B.H. Hahn, G.M. Shaw, and M.B. Oldstone. 1994. Virus specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103-6110.
24. Koup, R.A., J.T. Safrit, Y. Cao, C.A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D.D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650-4655.
25. James, J.A., T. Gross, R.H. Scofield, and J.B. Harley. 1995. Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B′-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity. J. Exp. Med. 181:453-461.